Rosetta Licenses Resolver to COR Therapeutics

Nov 26, 2001

NEW YORK, Nov. 26 - Rosetta Biosoftware announced on Monday that it has licensed its Resolver gene-expression data-analysis system to COR Therapeutics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

In Brief This Week: WuXi NextCode, 10x Genomics, Synthego, and More
People in the News: Carlos Bustamante, Douglas Berthiaume, Christopher O'Connell, and More
Food Allergy GWAS Leads to Five Susceptibility Loci
BabySeq Carrier Results Go Beyond Commercial Carrier Tests, Inform Parents' Reproductive Plans
Konica Minolta Closes Ambry Genetics Acquisition
Physical Inactivity, Poor Sleep Can Amplify Genetic Risk of Obesity

The Scan

Who Are You?

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

'Problematic'

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Republicans Take on Peer Review

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

This Week in Science

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

Main menu